08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1152 20 1044 84 1023 164 998
ERLYTX 76 0 0 4 49 8 49
GI 169 4 209 13 158 24 146
GU 381 8 417 48 584 80 487
LEUK 166 0 0 13 158 25 152
LUNG 204 4 209 13 158 35 213
LYMPH 429 5 261 32 390 66 402
MELAN 8 0 0 0 0 2 12
MMYEL 109 0 0 3 37 14 85
MULT 51 1 52 1 12 5 30
OTHER 50 0 0 2 24 3 18
Total 2795 42 2192 213 2593 426 2592

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 200 1 52 16 195 34 207
ERLYTX 3 0 0 0 0 0 0
GI 1 0 0 1 12 1 6
GU 8 1 52 2 24 3 18
LEUK 616 7 365 49 597 104 633
LUNG 364 2 104 22 268 51 310
OTHER 14 0 0 4 49 5 30
PEOLC 81 0 0 0 0 4 24
PREV 233 1 52 8 97 20 122
SXQOL 657 6 313 47 572 117 712
Total 2177 18 938 149 1814 339 2062

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1152 20 1044 84 1023 164 998
CCD 200 1 52 16 195 34 207
ERLYTX 79 0 0 4 49 8 49
GI 170 4 209 14 170 25 152
GU 389 9 470 50 609 83 505
LEUK 782 7 365 62 755 129 785
LUNG 568 6 313 35 426 86 524
LYMPH 429 5 261 32 390 66 402
MELAN 8 0 0 0 0 2 12
MMYEL 109 0 0 3 37 14 85
MULT 51 1 52 1 12 5 30
OTHER 64 0 0 6 73 8 49
PEOLC 81 0 0 0 0 4 24
PREV 233 1 52 8 97 20 122
SXQOL 657 6 313 47 572 117 712
Total 4972 60 3131 362 4408 765 4656

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 706 9 470 44 536 88 536
ERLYTX 53 0 0 2 24 6 37
GI 129 4 209 12 146 22 134
GU 286 3 157 31 377 56 341
LEUK 102 0 0 8 97 15 91
LUNG 128 3 157 11 134 26 158
LYMPH 279 3 157 20 244 43 262
MELAN 8 0 0 0 0 2 12
MMYEL 61 0 0 1 12 10 61
MULT 19 0 0 0 0 2 12
OTHER 50 0 0 2 24 3 18
Total 1821 22 1150 131 1594 273 1662

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 147 0 0 11 134 21 128
ERLYTX 3 0 0 0 0 0 0
GI 1 0 0 1 12 1 6
GU 8 1 52 2 24 3 18
LEUK 252 1 52 13 158 36 219
LUNG 222 1 52 13 158 34 207
OTHER 14 0 0 4 49 5 30
PEOLC 66 0 0 0 0 4 24
PREV 232 0 0 7 85 19 116
SXQOL 484 3 157 38 463 91 554
Total 1429 6 313 89 1083 214 1302

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 894 10 522 63 767 127 773
CCD 171 0 0 11 134 22 134
ERLYTX 56 0 0 2 24 6 37
GI 139 4 209 16 195 27 164
GU 328 4 209 37 450 70 426
LEUK 357 1 52 21 256 53 323
LUNG 379 3 157 30 365 67 408
LYMPH 279 3 157 20 244 43 262
MELAN 8 0 0 0 0 2 12
MMYEL 61 0 0 1 12 10 61
MULT 44 0 0 5 61 8 49
OTHER 142 0 0 5 61 9 55
PEOLC 67 0 0 0 0 2 12
PREV 232 0 0 7 85 19 116
SXQOL 484 3 157 38 463 91 554
Total 3641 28 1463 256 3117 556 3386

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 981 19 991 77 937 153 931
ERLYTX 71 0 0 4 49 8 49
GI 98 2 104 8 97 12 73
GU 270 4 209 33 402 57 347
LEUK 136 0 0 10 122 21 128
LUNG 178 4 209 12 146 31 189
LYMPH 350 5 261 24 292 49 298
MMYEL 96 0 0 3 37 11 67
MULT 51 1 52 1 12 5 30
Total 2231 35 1826 172 2094 347 2112

08-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1907 16 835 130 1583 280 1705
AFFIL 132 1 52 4 49 11 67
CCOP/NCORP 1211 11 574 86 1047 196 1193
Non-SWOG 1720 30 1565 140 1705 276 1680
Total 4970 58 3026 360 4384 763 4645

08-SEP-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 1 Y 18-AUG-26
BREAST S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC 2 Y 18-AUG-26
LYMPH S2506 NHL, R/R MZL, Mozun +/- Zanu or Pola 1 Y 18-AUG-26

08-SEP-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 T 27-AUG-26
CCD S1703 Met Breast, STM-monitoring v Usual Care 1 N 15-AUG-26
LUNG A082002 Lung, Adv, Systemic Tx +/- SBRT 1 E 14-AUG-26

08-SEP-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 16
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 7
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 6
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
LUNG LUNGMAP NSCLC, Adv, Master 2 4
GU A032103 Urothelial, All Stg, MRD-Based Adj Tx 1 3
GU A032103 Urothelial, All Stg, MRD-Based Adj Tx 0 3
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3